Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 266

1.

Up-regulated aldo-keto reductase family 1 member B10 in chronic hepatitis C: association with serum alpha-fetoprotein and hepatocellular carcinoma.

Sato S, Genda T, Hirano K, Tsuzura H, Narita Y, Kanemitsu Y, Kikuchi T, Iijima K, Wada R, Ichida T.

Liver Int. 2012 Oct;32(9):1382-90. doi: 10.1111/j.1478-3231.2012.02827.x. Epub 2012 Jun 11.

2.

Impact of aldo-keto reductase family 1 member B10 on the risk of hepatitis C virus-related hepatocellular carcinoma.

Sato S, Genda T, Ichida T, Murata A, Tsuzura H, Narita Y, Kanemitsu Y, Ishikawa S, Kikuchi T, Mori M, Hirano K, Iijima K, Wada R, Nagahara A, Watanabe S.

J Gastroenterol Hepatol. 2016 Jul;31(7):1315-22. doi: 10.1111/jgh.13295.

PMID:
26758591
3.

Pretreatment AKR1B10 expression predicts the risk of hepatocellular carcinoma development after hepatitis C virus eradication.

Murata A, Genda T, Ichida T, Amano N, Sato S, Tsuzura H, Sato S, Narita Y, Kanemitsu Y, Shimada Y, Hirano K, Iijima K, Wada R, Nagahara A, Watanabe S.

World J Gastroenterol. 2016 Sep 7;22(33):7569-78. doi: 10.3748/wjg.v22.i33.7569.

4.

SUOX is a promising diagnostic and prognostic biomarker for hepatocellular carcinoma.

Jin GZ, Yu WL, Dong H, Zhou WP, Gu YJ, Yu H, Yu H, Lu XY, Xian ZH, Liu YK, Cong WM, Wu MC.

J Hepatol. 2013 Sep;59(3):510-7. doi: 10.1016/j.jhep.2013.04.028. Epub 2013 May 9.

PMID:
23665285
5.

Identification and expression analysis of the aldo-ketoreductase1-B10 gene in primary malignant liver tumours.

Heringlake S, Hofdmann M, Fiebeler A, Manns MP, Schmiegel W, Tannapfel A.

J Hepatol. 2010 Feb;52(2):220-7. doi: 10.1016/j.jhep.2009.11.005. Epub 2009 Nov 25.

PMID:
20036025
6.

Expression of aldo-keto reductase family 1 member b10 in the early stages of human hepatocarcinogenesis.

Tsuzura H, Genda T, Sato S, Murata A, Kanemitsu Y, Narita Y, Ishikawa S, Kikuchi T, Mori M, Hirano K, Iijima K, Wada R, Ichida T.

Int J Mol Sci. 2014 Apr 17;15(4):6556-68. doi: 10.3390/ijms15046556.

7.

Gene expression profiling reveals potential biomarkers of human hepatocellular carcinoma.

Jia HL, Ye QH, Qin LX, Budhu A, Forgues M, Chen Y, Liu YK, Sun HC, Wang L, Lu HZ, Shen F, Tang ZY, Wang XW.

Clin Cancer Res. 2007 Feb 15;13(4):1133-9.

8.

Serum microRNA panels as potential biomarkers for early detection of hepatocellular carcinoma on top of HCV infection.

Zekri AN, Youssef AS, El-Desouky ED, Ahmed OS, Lotfy MM, Nassar AA, Bahnassey AA.

Tumour Biol. 2016 Sep;37(9):12273-12286. Epub 2016 Jun 6.

PMID:
27271989
9.

Circulating miRNA-122, miRNA-199a, and miRNA-16 as Biomarkers for Early Detection of Hepatocellular Carcinoma in Egyptian Patients with Chronic Hepatitis C Virus Infection.

El-Abd NE, Fawzy NA, El-Sheikh SM, Soliman ME.

Mol Diagn Ther. 2015 Aug;19(4):213-20. doi: 10.1007/s40291-015-0148-1.

PMID:
26133725
10.
11.

High expression of aldo-keto reductase 1B10 is an independent predictor of favorable prognosis in patients with hepatocellular carcinoma.

Ha SY, Song DH, Lee JJ, Lee HW, Cho SY, Park CK.

Gut Liver. 2014 Nov;8(6):648-54. doi: 10.5009/gnl13406. Epub 2014 Oct 7.

12.

Expression of β-catenin protein in hepatocellular carcinoma and its relationship with alpha-fetoprotein.

Ren YJ, Huang T, Yu HL, Zhang L, He QJ, Xiong ZF, Peng H.

J Huazhong Univ Sci Technolog Med Sci. 2016 Dec;36(6):846-851. Epub 2016 Dec 7.

PMID:
27924522
13.

Genome-Wide Association Study Identifies TLL1 Variant Associated With Development of Hepatocellular Carcinoma After Eradication of Hepatitis C Virus Infection.

Matsuura K, Sawai H, Ikeo K, Ogawa S, Iio E, Isogawa M, Shimada N, Komori A, Toyoda H, Kumada T, Namisaki T, Yoshiji H, Sakamoto N, Nakagawa M, Asahina Y, Kurosaki M, Izumi N, Enomoto N, Kusakabe A, Kajiwara E, Itoh Y, Ide T, Tamori A, Matsubara M, Kawada N, Shirabe K, Tomita E, Honda M, Kaneko S, Nishina S, Suetsugu A, Hiasa Y, Watanabe H, Genda T, Sakaida I, Nishiguchi S, Takaguchi K, Tanaka E, Sugihara J, Shimada M, Kondo Y, Kawai Y, Kojima K, Nagasaki M, Tokunaga K, Tanaka Y; Japanese Genome-Wide Association Study Group for Viral Hepatitis.

Gastroenterology. 2017 May;152(6):1383-1394. doi: 10.1053/j.gastro.2017.01.041. Epub 2017 Feb 3.

14.

Expression of alpha-fetoprotein and albumin genes in human hepatocellular carcinomas: limitations in the application of the genes for targeting human hepatocellular carcinoma in gene therapy.

Ohguchi S, Nakatsukasa H, Higashi T, Ashida K, Nouso K, Ishizaki M, Hino N, Kobayashi Y, Uematsu S, Tsuji T.

Hepatology. 1998 Feb;27(2):599-607.

PMID:
9462663
15.

Molecular background of alpha-fetoprotein in liver cancer cells as revealed by global RNA expression analysis.

Saito S, Ojima H, Ichikawa H, Hirohashi S, Kondo T.

Cancer Sci. 2008 Dec;99(12):2402-9. doi: 10.1111/j.1349-7006.2008.00973.x. Epub 2008 Nov 24.

16.

Regulation of aldo-keto-reductase family 1 B10 by 14-3-3ε and their prognostic impact of hepatocellular carcinoma.

Liu TA, Jan YJ, Ko BS, Wu YJ, Lu YJ, Liang SM, Liu CC, Chen SC, Wang J, Shyue SK, Liou JY.

Oncotarget. 2015 Nov 17;6(36):38967-82. doi: 10.18632/oncotarget.5734.

17.
18.

Epidermal growth factor induces tumour marker AKR1B10 expression through activator protein-1 signalling in hepatocellular carcinoma cells.

Liu Z, Yan R, Al-Salman A, Shen Y, Bu Y, Ma J, Luo DX, Huang C, Jiang Y, Wilber A, Mo YY, Huang MC, Zhao Y, Cao D.

Biochem J. 2012 Mar 1;442(2):273-82. doi: 10.1042/BJ20111322.

PMID:
22329800
20.

Gene expression profiling unravels cancer-related hepatic molecular signatures in steatohepatitis but not in steatosis.

Starmann J, Fälth M, Spindelböck W, Lanz KL, Lackner C, Zatloukal K, Trauner M, Sültmann H.

PLoS One. 2012;7(10):e46584. doi: 10.1371/journal.pone.0046584. Epub 2012 Oct 10.

Supplemental Content

Support Center